{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:48:42Z","timestamp":1773676122149,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.yebeh.2010.01.017","type":"journal-article","created":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T09:39:21Z","timestamp":1266399561000},"page":"555-557","source":"Crossref","is-referenced-by-count":20,"title":["Improvement of non-paraneoplastic voltage-gated potassium channel antibody-associated limbic encephalitis without immunosuppressive therapy"],"prefix":"10.1016","volume":"17","author":[{"given":"Heidemarie","family":"Gast","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaspar","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner J.","family":"Z\u2019Graggen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian W.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2010.01.017_bib1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/01.WNL.0000122648.19196.02","article-title":"Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody","volume":"62","author":"Thieben","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2010.01.017_bib2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2010.01.017_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.1097","article-title":"Potassium channel antibodies in two patients with reversible limbic encephalitis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2010.01.017_bib4","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/WNL.55.12.1823","article-title":"Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy","volume":"55","author":"Bien","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2010.01.017_bib5","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1212\/01.wnl.0000276946.08412.ef","article-title":"Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy","volume":"69","author":"Bien","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2010.01.017_bib6","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1212\/01.wnl.0000312275.04260.a0","article-title":"Clinical spectrum of voltage-gated potassium channel autoimmunity","volume":"70","author":"Tan","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2010.01.017_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-0404.2005.00406.x","article-title":"FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology","volume":"111","author":"Fauser","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2010.01.017_bib8","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/01.wnl.0000187129.66353.13","article-title":"Serum antibodies in epilepsy and seizure-associated disorders","volume":"65","author":"McKnight","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2010.01.017_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2007.11.004","article-title":"CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis","volume":"268","author":"Jarius","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2010.01.017_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eplepsyres.2006.06.003","article-title":"Antibodies to voltage-gated potassium and calcium channels in epilepsy","volume":"71","author":"Majoie","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2010.01.017_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/brain\/awh363","article-title":"Cancer risk in people with epilepsy: the role of antiepileptic drugs","volume":"128","author":"Singh","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2010.01.017_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.canlet.2009.03.013","article-title":"Histone deacetylase inhibitors as anti-neoplastic agents","volume":"280","author":"Batty","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.yebeh.2010.01.017_bib13","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.lfs.2005.01.003","article-title":"Carbamazepine is an inhibitor of histone deacetylases","volume":"76","author":"Beutler","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.yebeh.2010.01.017_bib14","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/CDLI.12.4.560-561.2005","article-title":"Oxcarbazepine-induced immunoglobulin deficiency","volume":"12","author":"Knight","year":"2005","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505010000223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505010000223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T01:01:58Z","timestamp":1590627718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505010000223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1525505010000223"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2010.01.017","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}